Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egbert Oosterwijk

Showing results (101-110 of 190) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargetingFrank G van Schaijk, Matthias Broekema, Egbert Oosterwijk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imagingAlexander B Stillebroer, Catharina M L Zegers, Otto C Boerman, et al.
European Journal of Pharmacology|February 15, 2011
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IXMargarita T Murri-Plesko, Alzbeta Hulikova, Egbert Oosterwijk, et al.
Tissue Engineering. Part A|July 29, 2010
Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen biomatrices: key issues in growth factor additionJody E Nuininga, Martin J W Koens, Dorien M Tiemessen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2019
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with <sup>111</sup>In-girentuximabTim J van Oostenbrugge, Johan F Langenhuijsen, Egbert Oosterwijk, et al.
International Journal of Cancer|July 13, 2002
Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytesJoost L M Vissers, I Jolanda M De Vries, Linda P H Engelen, et al.
International Journal of Molecular Sciences|July 9, 2020
Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal FibroblastsAlejandra M Ruiz-Zapata, Andrea Heinz, Manon H Kerkhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibodyFrank G van Schaijk, Egbert Oosterwijk, Annemieke C Soede, et al.
The Journal of Urology|May 18, 2016
Tubular Constructs as Artificial Urinary ConduitsMarije Sloff, Vasileios Simaioforidis, Dorien M Tiemessen, et al.
International Journal of Pharmaceutics|October 17, 2012
Lyophilisomes as a new generation of drug delivery capsulesEtienne van Bracht, René Raavé, Wouter P R Verdurmen, et al.
Pageof 19

Showing results (101-110 of 190) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2005
Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargetingFrank G van Schaijk, Matthias Broekema, Egbert Oosterwijk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2011
Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imagingAlexander B Stillebroer, Catharina M L Zegers, Otto C Boerman, et al.
European Journal of Pharmacology|February 15, 2011
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IXMargarita T Murri-Plesko, Alzbeta Hulikova, Egbert Oosterwijk, et al.
Tissue Engineering. Part A|July 29, 2010
Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen biomatrices: key issues in growth factor additionJody E Nuininga, Martin J W Koens, Dorien M Tiemessen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2019
Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with <sup>111</sup>In-girentuximabTim J van Oostenbrugge, Johan F Langenhuijsen, Egbert Oosterwijk, et al.
International Journal of Cancer|July 13, 2002
Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytesJoost L M Vissers, I Jolanda M De Vries, Linda P H Engelen, et al.
International Journal of Molecular Sciences|July 9, 2020
Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal FibroblastsAlejandra M Ruiz-Zapata, Andrea Heinz, Manon H Kerkhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibodyFrank G van Schaijk, Egbert Oosterwijk, Annemieke C Soede, et al.
The Journal of Urology|May 18, 2016
Tubular Constructs as Artificial Urinary ConduitsMarije Sloff, Vasileios Simaioforidis, Dorien M Tiemessen, et al.
International Journal of Pharmaceutics|October 17, 2012
Lyophilisomes as a new generation of drug delivery capsulesEtienne van Bracht, René Raavé, Wouter P R Verdurmen, et al.
Pageof 19